 |
|
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim
Clin Mol Hepatol. 2015;21(2):131-140. Published online 2015 Jun 26 DOI: https://doi.org/10.3350/cmh.2015.21.2.131
|
|
Citations to this article as recorded by
 A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients
Kehui Liu, Xiaogang Xiang, Rebecca Bao, Rong Chen, Yunye Liu, Jingdong Xie, Qing Guo, Shisan Bao, Qing Xie, Hui Wang
Scientific Reports.2016;[Epub] CrossRef Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand
Aung Myint Thu, Kittiyod Poovorawan, Chatporn Kittitrakul, Apichart Nontprasert, Natthida Sriboonvorakul, Weerapong Phumratanaprapin, Pisit Tangkijvanich, Wattana Leowattana, Polrat Wilairatana
BMC Pharmacology and Toxicology.2015;[Epub] CrossRef
|